Dimethyloxohexylxanthine en es it fr

Dimethyloxohexylxanthine Brand names, Dimethyloxohexylxanthine Analogs

Dimethyloxohexylxanthine Brand Names Mixture

  • No information avaliable

Dimethyloxohexylxanthine Chemical_Formula


Dimethyloxohexylxanthine RX_link


Dimethyloxohexylxanthine fda sheet

Dimethyloxohexylxanthine FDA

Dimethyloxohexylxanthine msds (material safety sheet)

Dimethyloxohexylxanthine Synthesis Reference

Mohler et al., U.S. Pat. 3,422,107 (1969)

Dimethyloxohexylxanthine Molecular Weight

278.307 g/mol

Dimethyloxohexylxanthine Melting Point


Dimethyloxohexylxanthine H2O Solubility

77 mg/mL

Dimethyloxohexylxanthine State


Dimethyloxohexylxanthine LogP

No information avaliable

Dimethyloxohexylxanthine Dosage Forms

Tablet (extended-release)

Dimethyloxohexylxanthine Indication

For the treatment of patients with intermittent lameness or immobility arising from chronic occlusive arterial disease of the limbs.

Dimethyloxohexylxanthine Pharmacology

Pentoxifylline, a synthetic dimethylxanthine derivative structurally related to theophylline and caffeine, is used in the treatment of peripheral vascular diseases and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.

Dimethyloxohexylxanthine Absorption

No information avaliable

Dimethyloxohexylxanthine side effects and Toxicity

LD50=1385 mg/kg(orally in mice)

Dimethyloxohexylxanthine Patient Information

No information avaliable

Dimethyloxohexylxanthine Organisms Affected

Humans and other mammals